The effect of botulinum toxin on ureteral inflammation
- PMID: 32696129
- DOI: 10.1007/s00345-020-03365-y
The effect of botulinum toxin on ureteral inflammation
Abstract
Purpose: The impact of onabotulinum toxin type A (BoNT-A) on bladder afferent nerve pathways and chemosensory functions is an active area of investigation. There may be a role for BoNT-A in disorders of the ureter; however, no histologic studies have assessed the effects of BoNT-A on ureteral tissue. Our objective was to develop an animal model of ureteral inflammation and determine the impact of ureteral BoNT-A instillation on known mechanisms of inflammation.
Methods: The safety and feasibility of a novel animal model of ureteral inflammation was assessed. Through open cystotomy, the effect of ureteral BoNT-A instillation on inflammation was determined through H&E, masson's trichrome, Ki-67 stain, and prostaglandin E (PGE) synthase expression, a known marker of pain and inflammation in ureteral tissue. Urothelial microstructure was assessed using electron microscopy and standard histologic techniques.
Results: All experiments were carried to completion, and no systemic signs of botulinum toxicity were seen. BoNT-A exposure was associated with a decrease in PGE synthase expression in a dose-dependent fashion. BoNT-A exposure was not found to impact collagen deposition or cell proliferation. Disruption of tight junctions between urothelial cells was observed under conditions of inflammation.
Conclusion: We describe the feasibility of a novel in vivo model of ureteral inflammation and report the first histologic study of the effects of BoNT-A on the ureter. Preliminary findings show that BoNT-A attenuates ureteral PGE synthase expression under conditions of inflammation. The application of BoNT-A may provide anti-inflammatory and analgesic effects in the context of ureteral disorders.
Keywords: Botulinum toxin; Histology; Inflammation; Prostaglandin; Ureter.
Similar articles
-
Do we understand how botulinum toxin works and have we optimized the way it is administered to the bladder? ICI-RS 2014.Neurourol Urodyn. 2016 Feb;35(2):293-8. doi: 10.1002/nau.22797. Neurourol Urodyn. 2016. PMID: 26872570 Review.
-
Botulinum Toxin Paves the Way for the Treatment of Functional Lower Urinary Tract Dysfunction.Toxins (Basel). 2020 Jun 14;12(6):394. doi: 10.3390/toxins12060394. Toxins (Basel). 2020. PMID: 32545870 Free PMC article.
-
Targets for botulinum toxin in the lower urinary tract.Neurourol Urodyn. 2014 Jan;33(1):31-8. doi: 10.1002/nau.22445. Epub 2013 Jun 17. Neurourol Urodyn. 2014. PMID: 23775898 Review.
-
Involvement of substance P in the antinociceptive effect of botulinum toxin type A: Evidence from knockout mice.Neuroscience. 2017 Sep 1;358:137-145. doi: 10.1016/j.neuroscience.2017.06.040. Epub 2017 Jul 1. Neuroscience. 2017. PMID: 28673722
-
Botulinum Toxin A for Bladder Pain Syndrome/Interstitial Cystitis.Toxins (Basel). 2016 Jul 1;8(7):201. doi: 10.3390/toxins8070201. Toxins (Basel). 2016. PMID: 27376330 Free PMC article. Review.
References
-
- Nitti VW, Dmochowski R, Herschorn S et al (2013) OnabotulinumtoxinA for the treatment of patients with overactive bladder and urinary incontinence: results of a phase 3, randomized, placebo controlled trial. J Urology 189:2186–2193. https://doi.org/10.1016/j.juro.2012.12.022 - DOI
-
- Chuang Y-C, Kaufmann JH, Chancellor DD et al (2014) Bladder instillation of liposome encapsulated onabotulinumtoxina improves overactive bladder symptoms: a prospective, multicenter, double-blind, randomized trial. J Urology 192:1743–1749. https://doi.org/10.1016/j.juro.2014.07.008 - DOI
-
- Chermansky CJ, Chancellor MB (2016) Use of botulinum toxin in urologic diseases. Urology 91:21–32. https://doi.org/10.1016/j.urology.2015.12.049 - DOI - PubMed
-
- Bossowska A, Lepiarczyk E, Mazur U et al (2015) Botulinum toxin type A induces changes in the chemical coding of substance P-immunoreactive dorsal root ganglia sensory neurons supplying the porcine urinary bladder. Toxins 7:4797–4816. https://doi.org/10.3390/toxins7114797 - DOI - PubMed - PMC
-
- Lavin ST, Southwell BR, Murphy R et al (1998) Activation of neurokinin 1 receptors on interstitial cells of Cajal of the guinea-pig small intestine by substance P. Histochem Cell Biol 110:263–271. https://doi.org/10.1007/s004180050288 - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical